Drug Profile
Testosterone oral transmucosal film - Aquestive Therapeutics pipeline, September 2021
Alternative Names: MSRX-110; MSRX-110 oral filmLatest Information Update: 13 Nov 2021
Price :
$50
*
At a glance
- Originator MonoSol Rx
- Developer Aquestive Therapeutics
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Androgen receptor agonists; Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypogonadism
Most Recent Events
- 29 Sep 2021 Discontinued - Phase-II for Hypogonadism in Canada (Transmucosal) (Aquestive Therapeutics pipeline, September 2021)
- 18 Aug 2014 Phase-I/II clinical trials in Hypogonadism in Canada (Transmucosal)